Rathbones Group PLC Pfizer Inc Transaction History

Rathbones Group PLC

$19 Billion
Q3 2024

A detailed history of Rathbones Group PLC transactions in Pfizer Inc stock. As of the latest transaction made, Rathbones Group PLC holds 605,091 shares of PFE stock, worth $16 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

605,091

Previous 595,858 1.55%

Holding current value

$16 Million

Previous $16.7 Million 5.03%

% of portfolio

0.09%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $255,754 - $289,823	9,233 Added 1.55%	605,091 $17.5 Million
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $35,414 - $41,499	-1,402 Reduced 0.23%	595,858 $16.7 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $180,246 - $206,980	-6,962 Reduced 1.15%	597,260 $16.6 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $818,548 - $1.06 Million	-31,326 Reduced 4.93%	604,222 $17.4 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $4.6 Million - $5.38 Million	143,299 Added 29.11%	635,548 $21.1 Million
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $220,584 - $255,211	-6,107 Reduced 1.23%	492,249 $18.1 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $618,107 - $804,685	-15,692 Reduced 3.05%	498,356 $20.3 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $554,440 - $723,760	13,280 Added 2.65%	514,048 $26.4 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $1.48 Million - $1.81 Million	-33,852 Reduced 6.33%	500,768 $21.9 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $533,047 - $632,027	11,456 Added 2.19%	534,620 $28 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $306,067 - $379,256	-6,690 Reduced 1.26%	523,164 $27.1 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $37,188 - $55,125	-900 Reduced 0.17%	529,854 $31.3 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $2.61 Million - $3.36 Million	-66,622 Reduced 11.15%	530,754 $22.8 Million
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $809,124 - $916,601	-22,532 Reduced 3.63%	597,376 $23.4 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $1.89 Million - $2.13 Million	-56,289 Reduced 8.32%	619,908 $22.5 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $47,125 - $59,924	1,408 Added 0.21%	676,197 $24.9 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $2 Million - $2.34 Million	62,921 Added 10.28%	674,789 $24.8 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $486,076 - $589,682	-16,138 Reduced 2.57%	611,868 $20 Million
Q1 2020 May 04, 2020	BUY	$27.03 - $38.62 $564,602 - $806,694	20,888 Added 3.44%	628,006 $20.5 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $423,845 - $481,010	12,875 Added 2.17%	607,118 $23.8 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $2.73 Million - $3.54 Million	84,086 Added 16.48%	594,243 $21.4 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $104,912 - $117,792	2,837 Added 0.56%	510,157 $22.1 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $943,687 - $1.04 Million	25,165 Added 5.22%	507,320 $21.5 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $2.23 Million - $2.54 Million	57,981 Added 13.67%	482,155 $21 Million
Q3 2018 Oct 12, 2018	BUY	$34.47 - $41.81 $5.83 Million - $7.07 Million	169,107 Added 66.3%	424,174 $18.7 Million
Q2 2018 Jul 16, 2018	SELL	$32.98 - $35.16 $475,373 - $506,796	-14,414 Reduced 5.35%	255,067 $9.25 Million
Q1 2018 Apr 06, 2018	SELL	$31.91 - $37.02 $24.4 Million - $28.3 Million	-765,043 Reduced 73.95%	269,481 $9.56 Million
Q4 2017 Jan 24, 2018	BUY	$33.26 - $35.29 $106,265 - $112,751	3,195 Added 0.31%	1,034,524 $37.5 Million
Q3 2017 Oct 24, 2017	BUY	$31.0 - $34.15 $32 Million - $35.2 Million	1,031,329	1,031,329 $36.8 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Pfizer Inc Transaction History